TY  - GEN
AU  - Greenberg,H E
AU  - Gottesdiener,K
AU  - Huntington,M
AU  - Wong,P
AU  - Larson,P
AU  - Wildonger,L
AU  - Gillen,L
AU  - Dorval,E
AU  - Waldman,S A
TI  - A new cyclooxygenase-2 inhibitor, rofecoxib (VIOXX), did not alter the antiplatelet effects of low-dose aspirin in healthy volunteers
SN  - 0091-2700
PY  - 2000///1222
KW  - Adolescent
KW  - Adult
KW  - Aspirin
KW  - administration & dosage
KW  - Cyclooxygenase 2
KW  - Cyclooxygenase 2 Inhibitors
KW  - Cyclooxygenase Inhibitors
KW  - adverse effects
KW  - Double-Blind Method
KW  - Drug Interactions
KW  - Female
KW  - Humans
KW  - Isoenzymes
KW  - drug effects
KW  - Lactones
KW  - Male
KW  - Membrane Proteins
KW  - Platelet Aggregation
KW  - Platelet Aggregation Inhibitors
KW  - Prostaglandin-Endoperoxide Synthases
KW  - Sulfones
KW  - Thromboxane B2
KW  - blood
N1  - Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
ER  -